Loading organizations...
Loading organizations...
Develops human organ-on-a-chip platforms for therapeutic testing.
CN Bio has raised $29.8M across 2 funding rounds.
CN Bio has raised $29.8M in total across 2 funding rounds.
CN Bio has raised $29.8M in total across 2 funding rounds.
CN Bio's investors include Yuexing Su.
CN Bio has raised $29.8M across 2 funding rounds. Most recently, it raised $21.0M Series B in April 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 23, 2024 | $21.0M Series B | Yuexing Su | |
| Mar 2, 2020 | $8.8M Other Equity |